ArticleJournal of the American Society of Nephrology : JASN2025

Further Considerations on the Clinical Evaluation of Sotagliflozin in Type 1 Diabetes with CKD.

Rui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.